Abstract:It is now well-established that mesenchymal stem/stromal cells (MSCs) have potent tissue reparative/regenerative properties, and also exert profound anti-inflammatory and immunomodulatory effects. However, despite the abundant basic science and preclinical data highlighting the immense therapeutic potential of MSCs, we still lack an understanding of the true extent of the clinically beneficial effects of MSCs. This deficit in our clinical knowledge is due in large part to the fact that MSCs lack of effectors of cell migration, and, therefore, MSCs are incapable of parenchymal colonization at injured/inflamed tissues following the intravascular administration. In this regard, it is important to distinguish tissue "entrapment" from authentic tissue "recruitment" (also known as tissue "homing"). Entrapment, as the word implies, occurs as a consequence of these large cells (upwards of 20 μm in diameter) being distributed throughout the body in a stochastic fashion, a result of being terminally wedged within the lumen of microvessels. This microvascular lodgment occurs more frequently within sites of inflammation due to inflammation-induced vasodilation and increased blood flow to the affected tissue (the pathobiology of "rubor"). It thus may appear that MSCs possess the capacity to "seek" inflammatory sites, leading some investigators to comingle, inappropriately, the passive process of MSC tissue entrapment with the physiologically distinct, extravasation-dependent, process of tissue recruitment. In contrast to entrapment, tissue recruitment is a site-specific, active/metabolic process whereby the circulating cells expressly adhere to the target tissue endothelial cells and thereafter extravasate (this ability to cross the endothelial barrier is known as "transendothelial migration" or "transmigration"), with consequent parenchymal infiltration. The major advantage of parenchymal colonization is that MSCs release their payload of biologically active agents within the tissue itself, optimizing their capacity to sense the tissue microenvironment with the subsequent release of pertinent beneficial growth factors. In this fashion, MSCs can most effectively function in a paracrine/trophic manner, consistent with the conceptual acronym of the "MSC" being a "Medicinal Signaling Cell" as proffered by the late, pioneering, MSC investigator Dr. Arnold I. ("Arnie") Caplan. 1 Thus, the tissue-infiltrating MSC becomes a biologic factory in situ , whereas the released paracrine/trophic payload of an entrapped MSC is washed downstream by blood flow.

Mesenchymal Stem Cells Transmigrate Between and Directly Through Tumor Necrosis Factor‐α‐Activated Endothelial Cells Via Both Leukocyte‐Like and Novel Mechanisms

Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation

Systemically Infused Mesenchymal Stem Cells Show Different Homing Profiles in Healthy and Tumor Mouse Models

Limitation of in Vivo Models Investigating Angiogenesis in Breast Cancer.

Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells

Enforced HCELL expression: empowering "Step 1" to optimize the efficacy of mesenchymal stem/stromal cell therapy for stroke and other clinical conditions

Mesenchymal stromal cell-associated migrasomes: a new source of chemoattractant for cells of hematopoietic origin

Quantification of Malignant Breast Cancer Cell MDA-MB-231 Transmigration Across Brain and Lung Microvascular Endothelium

Molecular Crosstalk Between Macrophages and Mesenchymal Stromal Cells

Macrophage-Associated Mesenchymal Stem Cells Assume an Activated, Migratory, Pro-Inflammatory Phenotype with Increased IL-6 and CXCL10 Secretion

Mesenchymal Stem Cell Delivery Routes and Fate

Endomicroscopy Will Track Injected Mesenchymal Stem Cells in Rat Colitis Models.

The critical role of apoptosis in mesenchymal stromal cell therapeutics and implications in homeostasis and normal tissue repair

Abstract 200: Vascular Stem Cell Migration in Response to Monocyte Chemoattractant Protein-1 Promotes Neointima Lesion Formation

Investigational Study of Mesenchymal Stem Cells on Lung Cancer Cell Proliferation and Invasion

Abstract 491: Injury-Activated TGFβ Recruits MSCs for Vascular Remodeling

Gap Junction-Mediated Cell-Cell Interaction Between Transplanted Mesenchymal Stem Cells and Vascular Endothelium in Stroke

Vascular Endothelial Growth Factor secretion and immunosuppression are distinct potency mechanisms of Human Bone Marrow Mesenchymal Stromal Cells

Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-α and its possible role in wound healing

Mesenchymal Stem Cells Use Integrin beta1 Not CXC Chemokine Receptor 4 for Myocardial Migration and Engraftment

Neural Cell Adhesion Molecule Modulates Mesenchymal Stromal Cell Migration Via Activation of MAPK/ERK Signaling